In fiscal year 2025, Agilent Technologies's revenue by segment (products & services) are as follows:
Learn more about Agilent Technologies’s Revenue by Geography
Check out competitors to Agilent Technologies in a side-by-side comparison.
Explore additional financial metrics for Agilent Technologies.
| Agilent CrossLab | 1568000000 |
|---|---|
| Diagnostics and Genomics | 1409000000 |
| Life Sciences and Applied Markets | 3856000000 |
| Agilent CrossLab | 1644000000 |
|---|---|
| Diagnostics and Genomics | 1651000000 |
| Life Sciences and Applied Markets | 3215000000 |
| Agilent CrossLab | 2908000000 |
|---|---|
| Applied Markets | 1314000000 |
| Life Sciences and Applied Markets | 2726000000 |
The above chart shows Agilent Technologies's revenue percentage share by segment (products and services).
In fiscal year 2023, Agilent Technologies's revenue by segment is as follows:
The above chart shows Agilent Technologies's revenue percentage share by segment (products and services).
In fiscal year 2024, Agilent Technologies's revenue by segment is as follows:
The above chart shows Agilent Technologies's revenue percentage share by segment (products and services).
In fiscal year 2025, Agilent Technologies's revenue by segment is as follows:
| Products & Services (Percent Share) | 2023 | 2024 | 2025 |
|---|---|---|---|
| Agilent CrossLab | 22.95% | 25.25% | 41.85% |
| Diagnostics and Genomics | 20.62% | 25.36% | - |
| Life Sciences and Applied Markets | 56.43% | 49.39% | 39.23% |
| Applied Markets | - | - | 18.91% |
| Total Revenue | 100% | 100% | 100% |
The above chart shows the revenue trend of different segments of Agilent Technologies.
In fiscal year 2025, the Agilent CrossLab generated the most revenue ($2.91 B), and the Applied Markets generated the least revenue ($1.31 B).
The above chart shows growth drivers and a year-over-year comparison of different segments' revenue.
| Products & Services | 2023 | 2024 | 2025 |
|---|---|---|---|
| Agilent CrossLab | $1.57 B - |
$1.64 B
4.85%
|
$2.91 B
76.89%
|
| Applied Markets | - - | - - | $1.31 B - |
| Diagnostics and Genomics | $1.41 B - |
$1.65 B
17.18%
|
- - |
| Life Sciences and Applied Markets | $3.86 B - |
$3.22 B
16.62%
|
$2.73 B
15.21%
|
| Total Revenue | $6.83 B - |
$6.51 B
4.73%
|
$6.95 B
6.73%
|